Tess Fries

Tess Fries is the inventor and founder of Elixira, a patent-pending nanobot platform designed 2025 for lifelong, autonomous cancer prevention. She is also the founder of Nanoism, a medical discipline in preventive medicine that focuses on autonomous, lifelong prevention through the integration of nanotechnology, artificial intelligence, and self-powered nanoscale systems.

With a focus on bridging nanotechnology, biotechnology, and AI, Tess is dedicated to creating transformative healthcare solutions that transcend preventive medicine. Her vision is to accelerate the transition towards a world where advanced technology and ethics work hand in hand to eliminate disease and extend human health.